[go: up one dir, main page]

Tam et al., 1995 - Google Patents

Synthesis and applications of branched peptides in immunological methods and vaccines

Tam et al., 1995

Document ID
2235564784761328878
Author
Tam J
et al.
Publication year
Publication venue
Peptides: synthesis, structures & applications. Academic Press, Inc., New York, NY

External Links

Snippet

Synthesis and applications of branched peptides in immunological methods and vaccines Page 470 Synthesis and Applications of Branched Peptides in Immunological Methods and Vaccines James P. Tam Vanderbilt University Medical Center Department of Microbiology and …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers

Similar Documents

Publication Publication Date Title
Tam Recent advances in multiple antigen peptides
Wiesmüller et al. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator
US5882645A (en) Peptide compounds
WJESMÜLLER et al. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope‐specific B‐, T‐helper and T‐killer cell response
Vepřek et al. Peptide and glycopeptide dendrimers. Part I
Defoort et al. Macromolecular assemblage in the design of a synthetic AIDS vaccine.
AU2003249778B2 (en) Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
US5580563A (en) Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
AU2007327829B2 (en) Coiled-coil lipopeptide helical bundles and synthetic virus-like particles
Muller et al. Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin
Zeng et al. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens
Deprez et al. Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL
JP2006257095A (en) Heterodimer polypeptide immunogen carrier composition and method
Huang et al. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine
US6074650A (en) Membrane anchor/active compound conjugate, its preparation and its uses
Tam Synthesis and applications of branched peptides in immunological methods and vaccines
US6024964A (en) Membrane anchor/active compound conjugate, its preparation and its uses
JP3821305B2 (en) Cytotoxic T lymphocyte-derived lipopeptides and vaccines
Bessler et al. Bacterial cell wall components as immunomodulators—I. Lipopeptides as adjuvants for parenteral and oral immunization
US20110262473A1 (en) Synthetic vaccine component
EP0961793A1 (en) Polymers incorporating peptides
GB2282813A (en) Annular antigen scaffolds comprising thioether linkages
US20090104220A1 (en) Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity
Rajnavölgyi et al. Structural characteristics influencing the carrier function of synthetic branched polypeptides based on poly [Lys-(DL-Ala) 3)] backbone
Nardelli et al. The MAP system: A flexible and unambiguous vaccine design of branched peptides